Browse By Person: Pollock, Pamela

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 51.

Journal Article

Packer, Leisl M. & Pollock, Pamela M. (2015) Paralog-specific kinase inhibition of FGFR4: Adding to the arsenal of anti-FGFR agents. Cancer Discovery, 5(4), pp. 355-357.

Stelloo, Ellen, Bosse, Tjalling, Nout, Remi A., MacKay, Helen J., Church, David N., Nijman, Hans W., et al. (2015) Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Modern Pathology, 28, pp. 836-844.
Number of citations in Scopus 1

Painter, J.N., O'Mara, T.A., Batra, J., Cheng, T., Lose, F.A., Dennis, J., et al. (2014) Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Human Molecular Genetics, 24(5), pp. 1478-1492.

Powell, Matthew A., Sill, Michael W., Goodfellow, Paul J., Benbrook, Doris M., Lankes, Heather A., Leslie, Kimberly K., et al. (2014) A phase II trial of brivanib in recurrent or persistent endometrial cancer: An NRG oncology/gynecologic oncology group study. Gynecologic Oncology, 135(1), pp. 38-43.
Number of citations in Scopus 5
Number of citations in Web of Science® 3

Doudican, Nicole, Byron, Sara A., Pollock, Pamela M., & Orlow, Seth (2013) XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts. Anticancer Drugs, 24(2), pp. 181-188.
Number of full-text downloads 57
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Byron, Sara A., Chen, Huaibin, Wortmann, Andreas, Loch, David, Gartside, Michael, Dehkhoda, Farhad, et al. (2013) The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib and ponatinib ATP-competitive inhibitors. NeoPlasia, 15(8), pp. 975-988.
Number of full-text downloads 322
Number of citations in Scopus 9
Number of citations in Web of Science® 10

Getz, Gad, Gabriel, Stacey B., Cibulskis, Kristian, Lander, Eric, Sivachenko, Andrey, Sougnez, Carrie, et al. (2013) Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), pp. 67-73.
Number of citations in Scopus 311
Number of citations in Web of Science® 334

Loch, David & Pollock, Pamela M. (2012) Lineage-specific biomarkers predict response to FGFR inhibition. Cancer Discovery, 2, pp. 1081-1083.
Number of full-text downloads 39

Byron, Sara A., Loch, David C. , Wellens, Candice L., Wortmann, Andreas, Wu, Jiayi, Wang, John, et al. (2012) Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. BMC Molecular Cancer, 11(75).
Number of full-text downloads 394
Number of citations in Scopus 12
Number of citations in Web of Science® 9

Byron, Sara A., Loch, David, & Pollock, Pamela M. (2012) Fibroblast growth factor receptor inhibition synergizes with paclitaxel and doxorubicin in endometrial cancer cells. International Journal of Gynecological Cancer, 22(9), pp. 1517-1526.
Number of full-text downloads 74
Number of citations in Scopus 4
Number of citations in Web of Science® 3

Byron, Sara A., Gartside, Michael, Powell, Matthew A., Wellens, Candice L., Gao, Feng, Mutch, David G., et al. (2012) FGFR2 point mutations in 466 Endometrioid Endometrial Tumors : relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and Clinicopathological features. PLoS ONE, 7(2), e30801-e30801.
Number of full-text downloads 78
Number of citations in Scopus 32
Number of citations in Web of Science® 29

Wortmann, Andreas, He, Yaowu, Christensen, Melinda E., Linn, MayLa, Lumley, John W., Pollock, Pamela M., et al. (2011) Cellular settings mediating Src Substrate switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734. Journal of Biological Chemistry, 286(49), pp. 42303-42315.
Number of full-text downloads 62
Number of citations in Scopus 7
Number of citations in Web of Science® 7

Greulich, Heidi & Pollock, Pamela M. (2011) Targeting mutant fibroblast growth factor receptors in cancer. Trends in Molecular Medicine, 17(5), pp. 283-292.
Number of full-text downloads 363
Number of citations in Scopus 40
Number of citations in Web of Science® 37

Byron, Sara, Gartside, Michael, Wellens, Candice, Goodfellow, Paul, Birrer, Michael, Campbell, Ian, et al. (2010) FGFR2 mutations are rare across histologic subtypes of ovarian cancer. Gynecologic Oncology, 117(1), pp. 125-129.
Number of full-text downloads 92
Number of citations in Scopus 18
Number of citations in Web of Science® 16

Terzian, Tamara, Torchia, Enrique C., Dai, Daisy, Robinson, Steven E., Murao, Kazutoshi, Stiegmann, Regan A., et al. (2010) p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation. Pigment Cell and Melanoma Research, 23(6), pp. 781-794.
Number of citations in Scopus 29
Number of citations in Web of Science® 27

Pinnix, Chelsea, Lee, John, Liu, Zhao-Jun, McDaid, Ronan, Balint, Klara, Beverly, Levi, et al. (2009) Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Research, 69(13), pp. 5312-5320.
Number of full-text downloads 27
Number of citations in Scopus 57
Number of citations in Web of Science® 50

Byron, Sara A. & Pollock, Pamela M. (2009) FGFR2 as a molecular target in endometrial cancer. Future Oncology, 5(1), pp. 27-32.
Number of citations in Scopus 23
Number of citations in Web of Science® 20

Kalinina, Juliya, Byron, Sara, Makarenkova, Helen, Olsen, Shaun, Eliseenkova, Anna, Larochelle, William, et al. (2009) Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix. Molecular and Cellular Biology, 29(17), pp. 4663-4678.
Number of citations in Scopus 17
Number of citations in Web of Science® 15

Gartside, Michael, Chen, Huaibin, Ibrahimi, Omar, Byron, Sara, Curtis, Amy, Wellens, Candice, et al. (2009) Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research, 7(1), pp. 41-54.
Number of full-text downloads 272
Number of citations in Scopus 53
Number of citations in Web of Science® 51

Huynh, Hung, Ngo, Van Chanh, Fargnoli, Joseph, Ayers, Mark, Soo, Khee Chee, Nung, Koong Heng, et al. (2008) Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Clinical Cancer Research, 14(19), pp. 6146-6153.
Number of citations in Scopus 126
Number of citations in Web of Science® 113

Zhao, Zhen Zhen, Pollock, Pamela, Thomas, Shane, Treloar, Sue, Nyholt, Dale, & Montgomery, Grant (2008) Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. Human Reproduction, 23(7), pp. 1661-1668.
Number of citations in Scopus 7
Number of citations in Web of Science® 5

Byron, Sara, Gartside, Michael, Wellens, Candice, Mallon, Mary, Keenan, Jack, Powell, Matthew, et al. (2008) Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation. Cancer Research, 68(17), pp. 6902-6907.
Number of full-text downloads 165
Number of citations in Scopus 65
Number of citations in Web of Science® 60

Chen, Huaibin, Xu, Chong-Feng, Ma, Jinghong, Eliseenkova, Anna, Li, Wanqing, Pollock, Pamela, et al. (2008) A crystallographic snapshot of tyrosine trans-phosphorylation in action. Proceedings of the National Academy of Sciences of the United States of America, 105(50), pp. 19660-19665.
Number of citations in Scopus 27
Number of citations in Web of Science® 28

Pollock, Pamela, Gartside, Michael, Dejeza, L., Powell, Matthew, Mallon, M., Davies, H., et al. (2007) Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene: including Oncogene Reviews, 26(50), pp. 7158-7162.
Number of citations in Scopus 143
Number of citations in Web of Science® 128

Packer, Leisl, Pavey, Sandra, Parker, Andrew, Stark, Mitchell, Johansson, Peter, Clarke, Belinda, et al. (2006) Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN. Carcinogenesis: integrative cancer research, 27(9), pp. 1778-1786.
Number of citations in Scopus 38
Number of citations in Web of Science® 31

Qin, Jian-Zhong, Ziffra, Jeffrey, Stennett, Lawrence, Bodner, Barbara, Bonish, Brian, Chaturvedi, Vijaya, et al. (2005) Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Research, 65(14), pp. 6282-6293.
Number of citations in Scopus 180
Number of citations in Web of Science® 167

Walker, Graeme J., Indsto, James O., Sood, Raman, Faruque, Mezbah U., Hu, Ping, Pollock, Pam M., et al. (2004) Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval. Genes Chromosomes Cancer, 41(1), pp. 56-64.
Number of citations in Scopus 24
Number of citations in Web of Science® 23

Pavey, Sandra, Johansson, Peter, Packer, Leisl, Taylor, Jennifer, Stark, Mitchell, Pollock, Pamela M., et al. (2004) Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene, 23(23), pp. 4060-4067.
Number of citations in Scopus 128
Number of citations in Web of Science® 116

Qin, Jian-Zhong, Stennett, Lawrence, Bacon, Patricia, Bodner, Barbara, Hendrix, Mary J.C., Seftor, Richard E.B., et al. (2004) p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. Molecular Cancer Therapeutics, 3(8), pp. 895-902.
Number of citations in Scopus 95
Number of citations in Web of Science® 85

Pollock, P.M., Harper, U.L., Hansen, K.S., Yudt, L.M., Stark, M., Robbins, C.M., et al. (2003) High frequency of BRAF mutations in nevi. Nature Genetics, 33(1), pp. 19-20.
Number of citations in Scopus 885
Number of citations in Web of Science® 811

Pollock, P.M., Cohen-Solal, K., Sood, R., Namkoong, J., Martino, J.J., Koganti, A., et al. (2003) Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nature Genetics, 34(1), pp. 108-112.
Number of citations in Scopus 142
Number of citations in Web of Science® 133

Pollock, Pamela M. & Meltzer, Paul S. (2002) Lucky draw in the gene raffle. Nature, 417(6892), pp. 906-907.
Number of citations in Scopus 17
Number of citations in Web of Science® 13

Pollock, Pamela M. & Hayward, Nicholas K. (2002) Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines. Melanoma Research, 12(2), pp. 183-186.
Number of citations in Scopus 26
Number of citations in Web of Science® 23

Pollock, P.M., Walker, G.J., Glendening, J.M., Que Noy, T., Bloch, N.C., Fountain, J.W., et al. (2002) PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines. Melanoma Research, 12(6), pp. 565-575.
Number of citations in Scopus 46
Number of citations in Web of Science® 36

Pollock, Pamela M. & Meltzer, Paul S. (2002) A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell, 2(1), pp. 5-7.
Number of citations in Scopus 92
Number of citations in Web of Science® 80

Cook, Anthony L., Pollock, Pamela M., Welch, John, Walsh, Michael D., Bowman, Rayleen V., Baumann, Kathryn C., et al. (2001) CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin. International Journal of Cancer, 93(3), pp. 361-367.
Number of citations in Scopus 10
Number of citations in Web of Science® 9

Pollock, Pamela M., Welch, John, & Hayward, Nicholas K. (2001) Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Research, 61, pp. 1154-1161.
Number of citations in Scopus 63
Number of citations in Web of Science® 58

Pollock, Pamela M., Stark, Mitchell S., Palmer, Jane M., Walters, Marilyn K., Aitken, Joanne F., Martin, N. G., et al. (2001) Mutation analysis of the CDKN2A promoter in Australian melanoma families. Genes Chromosomes Cancer, 32(1), pp. 89-94.
Number of citations in Scopus 18
Number of citations in Web of Science® 16

Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406(6795), pp. 536-540.
Number of citations in Scopus 1,420
Number of citations in Web of Science® 1,250

Pollock, Pamela M., Spurr, Nigel, Bishop, Tim, Newton-Bishop, Julia, Gruis, Nelleke, van der Velden, Pieter A., et al. (1998) Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families : evidence for common founders and independent mutations. Human Mutation, 11(6), pp. 424-431.
Number of citations in Scopus 51
Number of citations in Web of Science® 46

Flores, Jose F., Pollock, Pamela M., Walker, Graeme J., Glendening, J. Michael, Lin, Amy H-T, Palmer, Jane M., et al. (1997) Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds. Oncogene, 15(24), pp. 2999-3005.
Number of citations in Scopus 64
Number of citations in Web of Science® 62

Foulkes, William D., Flanders, Tamar Y., Pollock, Pamela M., & Hayward, Nicholas K. (1997) The CDKN2A (p16) gene and human cancer. Molecular Medicine, 3(1), pp. 5-20.
Number of citations in Scopus 114
Number of citations in Web of Science® 116

Sun, Sophie, Pollock, Pamela M., Liu, Ling, Karimi, Sepideh, Jothy, Serge, Milner, Benedict J., et al. (1997) CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein. International Journal of Cancer, 73(4), pp. 531-536.
Number of citations in Scopus 40
Number of citations in Web of Science® 37

Castellano, Marina, Pollock, Pamela M., Walters, Marilyn K., Sparrow, Louise E., Down, Louise M., Gabrielli, Brian G., et al. (1997) CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Research, 57(21), pp. 4868-4875.
Number of citations in Scopus 103
Number of citations in Web of Science® 102

Grimmond, S., Lagercrantz, J., Drinkwater, C., Silins, G., Townson, S., Pollock, P.M., et al. (1996) Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Research, 6(2), pp. 124-131.
Number of citations in Scopus 97
Number of citations in Web of Science® 95

Pollock, Pamela M., Pearson, John V., & Hayward, Nicholas K. (1996) Compilation of somatic mutations of the CDKN2 gene in human cancers : non-random distribution of base substitutions. Genes Chromosomes and Cancer, 15(2), pp. 77-88.
Number of citations in Scopus 156
Number of citations in Web of Science® 167

Pollock, P.M., Yu, F., Qiu, L., Parsons, P.G., & Hayward, N.K. (1995) Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene, 11(4), pp. 663-668.
Number of citations in Scopus 104

Yulug, Isik G., Egan, Sean E., Pollock, Pamela M., & Fisher, Elizabeth M.C. (1993) A homologue of the Drosophila Son of sevenless gene maps to mouse chromosome 17. Genomics, 18(3), pp. 733-734.
Number of citations in Scopus 1
Number of citations in Web of Science® 6

Conference Item

Carroll, Julie-Anne, Janda, Monika, Rodgers, Jessica, Pollock, Pamela M., Choi, Jaz Hee-jeong, & Washington, Tracy L. (2014) ‘Healthy mobile check-ins’ study: using GIS in smartphones to track use of urban environment by survivors of endometrial cancer. In Australiasian Epidemiological Association Annual Scientific Meeting (AEA 2014), 8-10 October 2014, Aotea Centre, Auckland, New Zealand.
Number of full-text downloads 13

Review

Nickoloff, Brian J., Hendrix, Mary J.C., Pollock, Pamela M., Trent, Jeffrey M., Miele, Lucio, & Qin, Jian-Zhong (2005) Notch and NOXA-related pathways in melanoma cells. Journal of Investigative Dermatology Symposium Proceedings, 10(2), pp. 95-104.
Number of citations in Scopus 45
Number of citations in Web of Science® 38

Pollock, P.M. & Trent, J.M. (2000) The genetics of cutaneous melanoma. Clinics in Laboratory Medicine, 20(4), pp. 667-690.
Number of citations in Scopus 52
Number of citations in Web of Science® 43

This list was generated on Sat Aug 1 12:40:50 2015 AEST.